跳至主要内容
临床试验/RBR-43mg87
RBR-43mg87尚未招募未知

Effect of Supplementation of Resveratrol Sublingual on Oxidative And Inflammatory Stress Markers in Hemodialysis Patients with Chronic Kidney Disease

niversidade do Sul de Santa Catarina0 个研究点开始时间: 2017年10月17日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
20Y 至 —(—)

入选标准

  • Patients of both sexes; over the age of 19; diagnosis of chronic kidney disease and who have been on a regular hemodialysis program for at least 3 months, since this is the time used to confirm the chronicity of renal disease

排除标准

  • Patients with a history of hypersensitivity to resveratrol will be excluded from the study; patients with food allergy containing resveratrol;cancer patients; with acute renal failure; in use of anti-inflammatory drugs; use of omega 3 supplementation; bedridden patients

研究者

发起方
niversidade do Sul de Santa Catarina

相似试验